Clinical Trials Directory

Trials / Completed

CompletedNCT05203900

The Influence by Dietary Human Milk Oligosaccharide in Low Birth Weight Infants

An Investigation of the Influence by Dietary Human Milk Oligosaccharide on Growth Factors and Cytokines in Blood, and Gut Microbiota in Low Birth Weight Infants (a Non-blinded Pilot Clinical Study)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Meiji Co., Ltd. · Industry
Sex
All
Age
1 Month
Healthy volunteers
Not accepted

Summary

This study aims to investigate the concentration of various growth factors and cytokines in blood, and to examine the gut microbiota of low birth weight infants fed with formulas with or without Human Milk Oligosaccharide (HMO) supplement. Eligible low birth weight infants are allocated to two groups, Investigational formula (with HMO) or Control formula (without HMO). The subjects are taking the assigned formula when they need to be supplemented with formula. After the informed consent was obtained and eligibility was confirmed, the intervention period begins, and ends at the one-month-old medical check-up with the assessment of the various blood growth factors and cytokines, and the gut microbiota.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTInfant formula with Human Milk OligosaccharideAlthough breastfeeding is encouraged, the shortage is supplemented with the investigational formula. After obtaining the informed consent, the investigational formula is administered to infants under the doctor's direction until a medical check-up at one-month-old.
DIETARY_SUPPLEMENTInfant formula without Human Milk OligosaccharideAlthough breastfeeding is encouraged, the shortage is supplemented with the control formula. After obtaining the informed consent, the control formula is administered to infants under the doctor's direction until a medical check-up at one-month-old.

Timeline

Start date
2021-12-13
Primary completion
2023-05-24
Completion
2023-05-24
First posted
2022-01-24
Last updated
2023-07-03

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT05203900. Inclusion in this directory is not an endorsement.